
    
      38 patients with seasonal allergic rhinitis that have recently (within 20 months) ended a
      full subcutaneous immunotherapy protocol with birch or grass allergen with improvement but
      not full symptom relief are recruited. Study subjects are randomized to intralymphatic
      injections with placebo or ALK Alutard 5-grasses or birch.
    
  